Purpura Fulminans Due to Neisseria meningitidis Septicemia Treated With Adjunctive Hyperbaric Oxygen Therapy: A Case Report | Canada Hyperbarics Skip to main content
Case Report Cureus 2025

Purpura Fulminans Due to Neisseria meningitidis Septicemia Treated With Adjunctive Hyperbaric Oxygen Therapy: A Case Report

Bani Hammad N, Alghatam A, Aljalahma J, Albuainain N — Cureus, 2025

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers described the case of a 25-year-old man with severe blood poisoning and rapidly progressing skin necrosis who received hyperbaric oxygen therapy.

What They Found

They found that a 25-year-old male with severe purpura fulminans due to Neisseria meningitidis septicaemia experienced rapid deterioration despite prompt antibiotics and supportive care. After developing extensive skin necrosis, the patient received multiple hyperbaric oxygen therapy sessions, which helped preserve his limbs.

Canadian Relevance

No direct Canadian connection identified. Purpura fulminans is not a Health Canada-recognised indication for hyperbaric oxygen therapy.

Study Limitations

As a case report, this study describes the experience of only one patient, meaning its findings cannot be applied to all patients with purpura fulminans.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Case Report
Category Infection
Source Pubmed
PubMed ID 41523381
Year Published 2025
Journal Cureus

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 17, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology